logo

Clozapine for the Treatment Resistant Schizophrenic

   

Added on  2020-06-06

13 Pages3835 Words39 Views
Clozapine for the Treatment-Resistant Schizophrenic

Table of ContentsOverview:...............................................................................................................................1Title:.......................................................................................................................................1Clozapine for the Treatment-Resistant Schizophrenic...................................................................1Abstract:.................................................................................................................................1Introduction................................................................................................................................................1Methodology...........................................................................................................................2Patients:..................................................................................................................................3Treatment:...............................................................................................................................3Procedures for prevention:.....................................................................................................4End points:..............................................................................................................................5Discussion...............................................................................................................................5APPENDIX .....................................................................................................................................6REFERENCES................................................................................................................................9

Overview:Clozapine medicine is an antipsychotic drug which is used by the patients who aresuffering from nervousness, tension, anxiety symptoms, and seizures. The main function ofclozapine is to treat severe schizophrenia. It is a kind of disease which affects the mind of thepatients who are suffering from. This is characterized by the abnormal social behaviour and failsto recognise what is genuine (Ripke and et. Al., 2014.). There are so many symptoms whichreflects Schizophrenia disease. Some common functions are: false beliefs, unclear or puzzledthinking, hearing voices which others can hear, limited social engagement and many more.Schizophrenia creates mental issues and emotional problems for the patients who are infectedwith this. For controlling this, Clozapine is used for limiting the role of schizo affective disorderthis may reduce the rate of suicidal behaviour. Title: Clozapine for the Treatment-Resistant SchizophrenicAbstract:This is segregated into many parts, which are comprised succinctly to render an overviewprior to reading the article in depth. This renders what research is expected to find in terms ofclozapine efficacy. The background and tools are easy to adopt, describing briefly how trial wasconvened. In 20th century, there was a famous psychiatrist Kurt Schneider listed the forms ofpsychotic symptoms. They covers delusions of being managed by external forces, belief whichviewpoints are being come into or withdrawn from one's conscious mind. The history ofSchizophrenia is complicated and that was not easily be identified by the people and scientists.But on the basis of the few symptoms, these are identified in an effective manner.1

IntroductionWith the emergence of chlorpromazine, various others factors chemical classes andcompounds with antipsychotic action which have been implemented. Despite substantial changesin the chemical structure, these agents likely to share an ability to bind to dopamine receptors.When in vitro binding assays are implemented, anti-dopaminergic action and therapeutic potencyare more associated. To more or less degree, these are known as neuroleptics which is connectedwith short term extrapyramidal side effects and share long term accountability of promptingtardive dyskinesia. Despite diverse comparative trails, there are no data which is consistent dataadvising that any particular antipsychotic drug which is very effective in treating schizophrenia.Over the last decade, significant efforts are made for emergence and testing of potentialantipsychotic compounds designated atypical. The main theme of atypicality is a workingconcept instead of a well delineated and validated classification. Commonly, this term is appliedto elaborate drugs which emerge to have certain short term extrapyramidal effects in human. The introduction is short and link up with regards to the issues with the mood of thepatients and urge them to do something wrong like- suicidal behaviour. This is happening due tothe environmental and genetic factors. Environmental issues are covered during adolescence,diverse infections, parental infections, parental age and nutrition at the time pregnancy. Geneticissues cover so many varieties. This disease does not apply a cover personality or dissociativeidentity disorder conditions with which this is usually confused in the public perception (Ripkeand et. al., 2013).MethodologyThere are two types of methodologies. Which have genetic and environment. However,there is a strong need to opt certain policies which would help affected patients to overcomeissues associated to these problems. These genetic and environmental issues play a role in theemergence of schizophrenia. People with a family history of schizophrenia who are having atransient psychosis have a 20-40% possibilities of being diagnosed after one year.Genetic: Forecasting of the habitability of Schizophrenia is almost 80% thatdemonstrates that 80% of the individual risk to schizophrenia is elaborated by individualdifferences in genetics. Such kind of predictions change due to the complication in segregatinggenetic and environmental influences. The higher single risk factor for emerging schizophrenia isis having a first degree connection with the disease; more than 40% of monozygotic twins of2

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
Schizophrenia Treatment & Management - Doc
|12
|1559
|67

Critical Analysis of Clozapine Treated Inpatients PDF
|10
|3392
|39

Antipsychotic Use and Idiopathic Venous Thromboembolism
|6
|1343
|237

Psychotropic Medicine | Nursing Assignment
|11
|2645
|11

Assessment of Psychotropic Medications in Healthcare
|12
|1062
|389